Cell cast acrylic is the raw material used to create the barriers in almost every public space, where one person must interact with another, throughout the entire United States. Cell cast acrylic production in the United States is limited. Imposing duties on products that do not threaten U.S. manufacturing and in fact, create thousands of fabrication and installation jobs, would have resulted in high COVID barrier costs which would have siphoned funds from the purchase of all types of PPE’s during this pandemic.

Put differently: the materials for the plastic barriers now installed everywhere aren’t available from U.S. sources, and GSP helps keep costs low so money can be better spent on other protective measures.

The acrylics example is important for two reasons: 1) everyone has seen the new plastic barriers even if they don’t know what they’re made from, and 2) they would never be classified as a “medical product” in the traditional sense of “what’s needed to battle Covid-19?” For example, they are nowhere to be found in the USITC’s recent report COVID-19 Related Goods: U.S. Imports and Tariffs.

The trade data shows demand for cell cast acrylics has surged in recent months. Compared to 2019, GSP imports were up about 80% in May 2020, 130% in June, and nearly 200% in July. Non-GSP imports were flat in May, up 50% in June and up 100% in July – still strong but clearly showing the important role of GSP benefits in meeting this new demand.

Importers of similar products, such as rubber gloves, have reported similar expectations. One importer of non-medical gloves said current demand for rubber gloves is at least twice – and perhaps as much as nine times – global manufacturing capacity. While lost GSP won’t reduce demand, it could mean up to $10 million annually in extra taxes on rubber gloves alone.

Face masks from Thailand, which lost GSP in April, are the flip side of the coin. Lost GSP won’t reduce Covid-driven demand, but it will raise costs for Americans responding to the pandemic. Congressional failure to renew GSP would add acrylic barriers, rubber gloves, and many other to the list of Covid-related products made “more expensive than necessary” due to tariffs.

Given the strong bipartisan support for GSP (here, or more recently here), hopefully Congress will act soon to avoid this and many other painful tariff hikes for American companies, workers, and consumers.

The top states by GSP savings have been fairly consistent over the years. California accounts for more than a quarter of GSP savings – about as much as the next 4 states (Florida, New York, Texas, New Jersey) combined. Washington and Tennessee have moved into the top 10 states in 2020, replacing Pennsylvania and North Carolina.

Savings are down sharply, from $555 million in 2019 to $407 million in 2020. The map below shows the widespread declines, with the Mountain West being a notable exception. Washington, Idaho, Wyoming, Utah, Colorado, and Arizona form a string of growth states from the Canadian to Mexican borders. Colorado’s savings increased over 150% from 2019, largely driven by a jump in backpack imports. Massachusetts is the only other state where GSP savings are up in the first half of 2020.

Savings declined by over 40% in more than 20 states, including a whopping 78% in Vermont. GSP savings also declined by 67% in Montana and Oklahoma, 63% in North Dakota, 61% in Michigan, 60% in Minnesota, and 52% in West Virginia.

Declines are NOT due to Covid-19. American companies have paid up to $183 million in extra tariffs in 2020 due to GSP suspensions for India, Turkey, and Thailand. In the first half of 2019, tariffs paid due to suspensions (India and Turkey only) were about $35 million. Add those potential savings to actual savings in both years, and the first half totals were nearly identical ($590 million) in spite of Covid-19-related declines. Our next post will dig into state-by-state costs in 2020 associated with the suspensions.